Cargando…
In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate
This study aimed to design a novel chimeric protein in silico to serve as a serotype-independent vaccine candidate against Shigella. The chimera contains amino acid residues 240–460 of Shigella invasion plasmid antigen B (IpaB) and the C-terminus of Clostridium perfringens enterotoxin (C-CPE). Amino...
Autores principales: | Arabshahi, Sina, Nayeri Fasaei, Bahar, Derakhshandeh, Abdollah, Novinrooz, Aytak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972921/ https://www.ncbi.nlm.nih.gov/pubmed/29091543 http://dx.doi.org/10.1080/21655979.2017.1373535 |
Ejemplares similares
-
In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli
por: Novinrooz, Aytak, et al.
Publicado: (2017) -
Expression of Shigella flexneri ipaB Gene in Tobacco
por: Ohadi, Mandana, et al.
Publicado: (2013) -
The Many Faces of IpaB
por: Picking, Wendy L., et al.
Publicado: (2016) -
Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis
por: Meron-Sudai, Shiri, et al.
Publicado: (2022) -
Structural Insights of Shigella Translocator IpaB and Its Chaperone IpgC in Solution
por: Ferrari, Mariana L., et al.
Publicado: (2021)